Mattia Pasqua

Dr. Mattia Pasqua

Fondazione Ri.MED
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2022 in Cells
Verified
Journal Article
Open access
PDF file
Antonietta MessinaAntonietta Messina
Antonietta Messina
ELEléanor Luce
Eléanor Luce
NBNassima BENZOUBIR
Nassima BENZOUBIR
Mattia PasquaMattia Pasqua
Mattia Pasqua
UPUlysse Pereira
Ulysse Pereira
ADAnne Dubart-Kupperschmitt
Anne Dubart-Kupperschmitt
Background: Human-induced pluripotent stem cell-derived hepatocytes (iHeps) have been shown to have considerable potential in liver diseases, toxicity, and pharmacological studies. However, there is a growing need to obtain iHeps that are truly similar to primary adult hepatocytes in terms of morphological features and functions. We generated such human iHeps, self-assembled as organoids (iHep-Orgs). Methods: iPSC-derived hepatoblasts were self-assembled into spheroids and differentiated into mature hepatocytes modulating final step of differentiation. Results: In about four weeks of culture, the albumin secretion levels and the complete disappearance of α-fetoprotein from iHep-Orgs suggested the acquisition of a greater degree of maturation than those previously reported. The expression of apical transporters and bile acid secretion evidenced the acquisition of complex hepatocyte polarity as well as the development of a functional and well-defined bile canalicular network confirmed by computational analysis. Activities recorded for CYP450, UGT1A1, and alcohol dehydrogenase, response to hormonal stimulation, and glucose metabolism were also remarkable. Finally, iHep-Orgs displayed a considerable ability to detoxify pathological concentrations of lactate and ammonia. Conclusions: With features similar to those of primary adult hepatocytes, the iHep-Orgs thus produced could be considered as a valuable tool for the development and optimization of preclinical and clinical applications.

1 June 2020 in Tissue Engineering Part A
Verified
Journal Article
Closed access
Mattia PasquaMattia Pasqua
Mattia Pasqua
UPUlysse Pereira
Ulysse Pereira
AMAntonietta Messina
Antonietta Messina
CLClaire de Lartigue
Claire de Lartigue
PVPascale Vigneron
Pascale Vigneron
CLCecile Legallais
Cecile Legallais
In liver tissue engineering, cell culture in spheroids is now well recognized to promote the maintenance of hepatic functions. However, the process leading to spheroids formation is time consuming, costly, and not easy to scale-up for further use in human bioartificial liver (BAL) applications. In this study, we encapsulated HepaRG cells (precursors of hepatocyte-like cells) in 1.5% alginate beads without pre-forming spheroids. Starting from a given hepatic biomass, we analysed cell differentiation and metabolic performance for further use in a fluidized-bed BAL. We observed that cells self-rearranged as aggregates within the beads and adequately differentiated over time, in the absence of any differentiating factors classically used. On day 14 post-encapsulation, cells displayed a wide range of hepatic features necessary for the treatment of a patient in acute liver failure. These activities include albumin synthesis, ammonia and lactate detoxification and the efficacy of the enzymes involved in the xenobiotic metabolism (such as CYP1A1/2).

Verified
Journal Article
Open access
PDF file
Mattia PasquaMattia Pasqua
Mattia Pasqua
RGRoberto Di Gesù
Roberto Di Gesù
CCCinzia Chinnici
Cinzia Chinnici
PCPier Giulio Conaldi
Pier Giulio Conaldi
MFMaria Giovanna Francipane
Maria Giovanna Francipane
The possibility to reproduce key tissue functions in vitro from induced pluripotent stem cells (iPSCs) is offering an incredible opportunity to gain better insight into biological mechanisms underlying development and disease, and a tool for the rapid screening of drug candidates. This review attempts to summarize recent strategies for specification of iPSCs towards hepatobiliary lineages —hepatocytes and cholangiocytes—and their use as platforms for disease modeling and drug testing. The application of different tissue-engineering methods to promote accurate and reliable readouts is discussed. Space is given to open questions, including to what extent these novel systems can be informative. Potential pathways for improvement are finally suggested.

10 March 2023 in Cells
Verified
Journal Article
Open access
PDF file
MHmarwa hussein
marwa hussein
Mattia PasquaMattia Pasqua
Mattia Pasqua
UPUlysse Pereira
Ulysse Pereira
NBNassima BENZOUBIR
Nassima BENZOUBIR
Jean-Charles Duclos-ValléeJean-Charles Duclos-Vallée
Jean-Charles Duclos-Vallée
Antonietta MessinaAntonietta Messina
Antonietta Messina
Liver cell therapy and in vitro models require functional human hepatocytes, the sources of which are considerably limited. Human induced pluripotent stem cells (hiPSCs) represent a promising and unlimited source of differentiated human hepatocytes. However, when obtained in two-dimensional (2D) cultures these hepatocytes are not fully mature and functional. As three-dimensional culture conditions offer advantageous strategies for differentiation, we describe here a combination of three-dimensional (3D) approaches enabling the successful differentiation of functional hepatocytes from hiPSCs by the encapsulation of hiPSC-derived hepatoblasts in alginate beads of preformed aggregates. The resulting encapsulated and differentiated hepatocytes (E-iHep-Orgs) displayed a high level of albumin synthesis associated with the disappearance of α-fetoprotein (AFP) synthesis, thus demonstrating that the E-iHep-Orgs had reached a high level of maturation, similar to that of adult hepatocytes. Gene expression analysis by RT-PCR and immunofluorescence confirmed this maturation. Further functional assessments demonstrated their enzymatic activities, including lactate and ammonia detoxification, as well as biotransformation activities of Phase I and Phase II enzymes. This study provides proof of concept regarding the benefits of combining three-dimensional techniques (guided aggregation and microencapsulation) with liver differentiation protocols as a robust approach to generate mature and functional hepatocytes that offer a permanent and unlimited source of hepatocytes. Based on these encouraging results, our combined conditions to produce mature hepatocytes from hiPSCs could be extended to liver tissue engineering and bioartificial liver (BAL) applications at the human scale for which large biomasses are mandatory.

9 October 2020 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
Mattia PasquaMattia Pasqua
Mattia Pasqua
UPUlysse Pereira
Ulysse Pereira
CLClaire de Lartigue
Claire de Lartigue
JNJonathan Nicolas
Jonathan Nicolas
PVPascale Vigneron
Pascale Vigneron
CLCecile Legallais
Cecile Legallais

16 June 2025 in Advanced Healthcare Materials
Verified
Journal Article
Open access
Mattia PasquaMattia Pasqua
Mattia Pasqua
MBMarianna Barbuto
Marianna Barbuto
MCMatteo Calligaris
Matteo Calligaris
RGRoberto Di Gesù
Roberto Di Gesù
Duilio PaganoDuilio Pagano
Duilio Pagano
MFMaria Giovanna Francipane
Maria Giovanna Francipane
Tissue engineering offers new hope for treating biliary defects. Several scaffolds have been proposed, but their properties have not been fully investigated. In this study, the design, fabrication, and characterization of a novel common bile duct (CBD)‐like prototype are described. This prototype combines two biocompatible biomaterials, methacrylated type I collagen (CollMA) and poly(ε‐caprolactone) (PCL), along with biliary epithelial cells. CollMA supports the organization of biliary epithelial cells into a functional biliary‐like epithelium, as shown by histological, functional, and proteomic assays, while PCL provides mechanical strength. The biological and mechanical phases of the prototype are integrated into a multiphasic tubular scaffold using molding and electrospinning techniques. The final CBD‐like prototype consists of three interpenetrating phases: from innermost to outermost, these are biliary epithelial cell‐laden CollMA, PCL, and CollMA. This design overcomes challenges seen in multilayer constructs, such as interlayer delamination and lack of homogeneity. The prototype remains stable under physiological conditions, enables bile flow without leakage, and exhibits bile acid transport and modification activities, warranting future in vivo preclinical evaluation. In an ex vivo human blood assay, the acellular prototype elicited a favorable immune response, limiting inflammation and promoting sustained release of epidermal growth factor (EGF), indicating its potential to support regenerative processes.